Healthcare - Biotechnology - NASDAQ - US
$ 1.98
-4.81 %
$ 29.4 M
Market Cap
-0.22
P/E
BALANCE SHEET
12.1 M
ASSETS
5.34 M
LIABILITIES
6.74 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Longeveron Inc.
| Current Assets | 5.85 M |
| Cash & Short-Term Investments | 5.36 M |
| Receivables | 111 K |
| Other Current Assets | 376 K |
| Non-Current Assets | 6.23 M |
| Long-Term Investments | 0 |
| PP&E | 3.75 M |
| Other Non-Current Assets | 2.48 M |
| Current Liabilities | 3.89 M |
| Accounts Payable | 638 K |
| Short-Term Debt | 1.19 M |
| Other Current Liabilities | 2.06 M |
| Non-Current Liabilities | 1.45 M |
| Long-Term Debt | 1.45 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 4.9 | 10.5 | 25.7 | 0.8 | 1.9 | 4.0 |
| Short Term Investments | 0.4 | 9.2 | 9.4 | 0 | 0 | 0 |
| Receivables | 0.1 | 0.2 | 55 K | 0.4 | 0.5 | 0 |
| Inventory | 0 | (0.6) | 0 | 0 | 0 | 0 |
| Other Current Assets | 0.4 | 0.4 | 0.6 | 0.6 | 53.8 K | 0.1 |
| Total Current Assets | 5.8 | 19.7 | 35.4 | 1.8 | 2.4 | 4.2 |
| PP&E | 3.8 | 2.9 | 4.9 | 5.7 | 6.5 | 4.8 |
| Intangible Assets | 2.3 | 2.4 | 2.3 | 1.5 | 1.5 | 1.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.2 | 100 K | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 2.4 | 0.2 | 0.2 | 0.3 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 12.1 | 27.4 | 42.8 | 9.2 | 10.6 | 10.5 |
| LIABILITIES | ||||||
| Accounts Payable | 0.6 | 1.8 | 0.6 | 1.6 | 1.2 | 1.2 |
| Short Term Debt | 1.2 | 1.1 | 1.1 | 0.7 | 0.5 | 0 |
| Other Current Liabilities | 1.0 | 1.5 | 0.3 | 1.5 | 0.3 | 0.3 |
| Total Current Liabilities | 3.9 | 4.9 | 2.7 | 3.8 | 2.5 | 1.9 |
| Long Term Debt | 1.4 | 2.0 | 2.6 | 3.5 | 3.7 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 368 | 0 | 1.8 |
| Total Liabilities | 5.3 | 6.9 | 5.3 | 7.3 | 6.1 | 3.7 |
| EQUITY | ||||||
| Common Stock | 25 K | 21 K | 21 K | 16 K | 4.6 | 7.1 |
| Retained Earnings | (85.0) | (62.8) | (43.9) | (26.9) | 0 | 0 |
| Other Accumulative Comprehensive Income/Loss | 100 K | (0.4) | 100 K | 100 K | (0.1) | (1.4) |
| Total Equity | 6.7 | 20.5 | 37.5 | 2.0 | 4.4 | 6.8 |
| Total Liabilities and Equity | 12.1 | 27.4 | 42.8 | 9.2 | 10.6 | 10.5 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 2.2 | 2.1 | 2.1 | 1.9 | 1.9 | 15.9 |